GDF15 and atherosclerosis: The broad involvement of GDF15 in diverse cardiovascular and systemic conditions, involving inflammation, metabolic dysregulation, atherosclerosis, and endothelial impairment, likely underpins its strong prognostic association with adverse limb events in PAD patients, as observed in our study [43].